Investigating the Impact of Drug Crystallinity in Amorphous Tacrolimus Capsules on Pharmacokinetics and Bioequivalence Using Discriminatory In Vitro Dissolution Testing and Physiologically Based Pharmacokinetic Modeling and Simulation
Journal of Pharmaceutical Sciences2017Vol. 107(5), pp. 1330–1341
Citations Over TimeTop 11% of 2017 papers
Hitesh S. Purohit, Niraj S. Trasi, Dajun Sun, Edwin C.Y. Chow, Hong Wen, Xinyuan Zhang, Yi Gao, Lynne S. Taylor
Related Papers
- → Coupling biorelevant dissolution methods with physiologically based pharmacokinetic modelling to forecast in-vivo performance of solid oral dosage forms(2013)69 cited
- → Evaluating bioequivalence of meloxicam tablets: is in-vitro dissolution test overdiscriminating?(2017)9 cited
- → Biopharmaceutics: 8. Relationship between Dosage Forms, Dosage Regimens and Pharmacokinetics(1969)5 cited
- [Dissolution testing combined with computer simulation technology to evaluate the bioequivalence of domestic amoxicillin capsule].(2014)
- → In vitro Dissolution and in vivo Bioequivalence Evaluation of Two Brands of Cefuroxime Axetil Tablets(2011)1 cited